Investigating allergy prevention, this research highlights early intervention strategies and the promise of biologic ...

“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical ...

As the future of rare disease research at Cincinnati Children's is threatened, parents of 13-year-old Charlie Evans plead for ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

If you've been using Zyrtec or Xyzal to combat your allergy symptoms this year, an FDA warning wants you to be aware of this ...

Two antihistamines, including Zyrtec, are under warning by the FDA after people reported “severe itching” after ceasing ...

Earlier this month, the U.S. Food and Drug Administration (FDA) issued a warning regarding two popular allergy medications. Specifically, the agency made clear that stopping long-term use of ...

The global food allergy market is experiencing remarkable growth, projected to reach a valuation of USD 66.15 Billion by the end of 2033, expanding at a CAGR of 5.2% from its estimated value of USD 39 ...

The U.S. Food and Drug Administration has issued a warning that people who have used certain common allergy medications may ...

Hundreds of people who stopped using allergy medications like Zyrtec and Xyzal noticed an uncomfortable new side effect, the ...

The US FDA issued a warning on Saturday that some popular allergy medications could cause a rare but severe itching side ...